Clinical trial
Efficacy Study of Dysport® in the Treatment of Anal Fissure.
NCT00210444 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00210444 |
|---|---|
| Title | Efficacy Study of Dysport® in the Treatment of Anal Fissure. |
| Official title | A Phase II, Multicentre, Open, Randomised, Parallel Group, Dose Ranging Study to Define the Efficacy of Dysport® in the Treatment of Anal Fissure. |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anal Fissure |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 168 |
| Start date | Jun 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 29, 2020 |
| Countries | Czechia, Poland, Romania, Tunisia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: